Aytu BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q2 2024 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q3 2024 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2025 | 1 | $0.15 | $0.15 | $0.15 |
| Q2 2025 | 1 | $0.48 | $0.48 | $0.48 |
Aytu BioPharma, Inc. Earnings Date And Information
Aytu BioPharma, Inc. last posted its earnings results on Thursday, September 26th, 2024. The company reported $-0.82 earnings per share for the quarter, missing analysts' consensus estimates of $-0.45 by $0.37. The company had revenue of 17.98 M for the quarter and had revenue of 81.00 M for the year. Aytu BioPharma, Inc. has generated $-3 earnings per share over the last year ($-2.86 diluted earnings per share) and currently has a price-to-earnings ratio of -0.66. Aytu BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Aytu BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/26/2024 | Q4 2024 | -$0.45 | -$0.82 | -0.37 | $18.30 M | $17.98 M |
| 05/15/2024 | Q3 2024 | -$0.64 | -$0.52 | 0.12 | $17.99 M | |
| 02/14/2024 | Q2 2024 | -$0.25 | -$0.04 | 0.21 | $22.93 M | |
| 11/14/2023 | Q1 2024 | -$0.04 | -$1.48 | -1.44 | $27.73 M | $22.10 M |
| 10/12/2023 | Q4 2023 | -$0.59 | $27.69 M | $30.73 M | ||
| 05/11/2023 | Q3 2023 | -$0.63 | -$1.93 | -1.3 | $22.73 M | |
| 02/21/2023 | Q2 2023 | $0.20 | -$2.15 | -2.35 | $26.28 M | |
| 02/21/2023 | Q1 2023 | $0.20 | -$0.28 | -0.48 | $24.30 M | $27.66 M |
| 09/27/2022 | Q4 2022 | -$4.80 | -$8.95 | -4.15 | $25.70 M | $27.45 M |
| 05/16/2022 | Q3 2022 | -$8.20 | -$35.90 | -27.7 | $24.20 M | |
| 02/14/2022 | Q2 2022 | -$7.09 | -$8.74 | -1.65 | $23.13 M | |
| 11/15/2021 | Q1 2022 | -$2.97 | -$435.20 | -432.23 | $22.10 M | $21.90 M |
| 02/22/2022 | Q4 2021 | -$16.20 | $24.70 M | $23.48 M | ||
| 05/17/2021 | Q3 2021 | -$7.20 | -$28.20 | -21 | $13.48 M | |
| 02/11/2021 | Q2 2021 | -$10.00 | -$14.40 | -4.4 | $15.15 M | |
| 11/12/2020 | Q1 2021 | -$12.00 | -$7.00 | 5 | $13.33 M | $13.52 M |
| 10/06/2020 | Q4 2020 | -$5.60 | $11.24 M | $14.86 M | ||
| 05/14/2020 | Q3 2020 | -$30.20 | $8.16 M | |||
| 02/14/2020 | Q2 2020 | -$2.40 | $3.18 M | |||
| 11/14/2019 | Q1 2020 | -$60.00 | -$64.32 | -4.32 | $2.02 M | $1.44 M |
Aytu BioPharma, Inc. Earnings: Frequently Asked Questions
-
When is Aytu BioPharma, Inc.'s earnings date?
Aytu BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Aytu BioPharma, Inc.'s earnings conference call?
The conference call for Aytu BioPharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Aytu BioPharma, Inc.'s conference call transcript?
The conference call transcript for Aytu BioPharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Aytu BioPharma, Inc. generate each year?
Aytu BioPharma, Inc. (:AYTU) has a recorded annual revenue of $81.00 M.
-
How much profit does Aytu BioPharma, Inc. generate each year?
Aytu BioPharma, Inc. (:AYTU) has a recorded net income of $81.00 M. Aytu BioPharma, Inc. has generated $-2.86 earnings per share over the last four quarters.
-
What is Aytu BioPharma, Inc.'s price-to-earnings ratio?
Aytu BioPharma, Inc. (:AYTU) has a price-to-earnings ratio of -0.66 and price/earnings-to-growth ratio is -0.03.
